Telesis Bio Inc (TBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 0 | 0 | 98,418 | 85,530 |
| Marketable Securities | N/A | 0 | 0 | 57,627 | 104,098 |
| Receivables | N/A | 0 | 0 | 6,228 | 4,596 |
| TOTAL | $N/A | $0 | $0 | $169,194 | $203,615 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 13,781 | 12,539 |
| Intangibles | 0 | 0 | 0 | 106,203 | 106,895 |
| Other Non-Current Assets | 0 | 0 | 0 | 16,064 | 13,152 |
| TOTAL | $N/A | $N/A | $N/A | $136,048 | $132,586 |
| Total Assets | $N/A | $0 | $0 | $305,242 | $336,201 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 6,297 | 15,968 |
| Accrued Expenses | N/A | 0 | 0 | 7,478 | 7,072 |
| TOTAL | $N/A | $0 | $0 | $41,108 | $41,670 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 26,760 | 18,100 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 106,134 | 115,739 |
| TOTAL | $N/A | $N/A | $N/A | $121,462 | $140,995 |
| Total Liabilities | $N/A | $0 | $0 | $162,570 | $182,665 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | 62,909 | 60,029 |
| Common Shares | N/A | 0 | 0 | 60 | 60 |
| Retained earnings | N/A | 0 | 0 | -373,778 | -359,496 |
| Other shareholders' equity | 0 | 0 | 0 | 855 | 741 |
| TOTAL | $N/A | $0 | $0 | $142,672 | $153,536 |
| Total Liabilities And Equity | $0 | $0 | $0 | $305,242 | $336,201 |